# Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma

> **NCT03909776** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 99 (actual)

## Conditions studied

- Event-free Survival
- Overall Survival
- Local-recurrence Free Survival
- Pathological Response

## Interventions

- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT03909776
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2019-04-01
- **Final completion:** 2019-04-08
- **Target enrollment:** 99 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03909776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03909776, "Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity Osteosarcoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03909776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*